5 results about "Viral pneumonia" patented technology

This invention relates to a traditional Chinese medicine composition for improving viral pneumonia, its preparation method, and its application, belonging to the field of traditional Chinese medicine technology. This invention provides a traditional Chinese medicine composition for improving viral pneumonia, comprising the following raw materials: Bambusa textilis, Gastrodia elata, Ziziphus jujuba, pearl, Arisaema cum bile, Bombyx mori, borneol, menthol, bezoar, pearl powder, scorpion, honeysuckle, Isatis indigotica, cicada slough, Forsythia suspensa, and licorice. The composition of this invention uses Ziziphus jujuba, bezoar, and honeysuckle as the principal herbs, clearing heat and detoxifying, resolving phlegm and calming the nerves, focusing on treating the root cause; Forsythia suspensa, Isatis indigotica, Arisaema cum bile, Bambusa textilis, Bombyx mori, Gastrodia elata, scorpion, and cicada slough as the assistant herbs, dispelling wind and heat, calming wind and resolving phlegm, enhancing the efficacy; pearl, pearl powder, borneol, and menthol as adjuvant herbs, heavily sedating and calming the mind, aromatic and opening the orifices; and licorice as the guiding herb, harmonizing the other herbs. The entire formula has the characteristics of simultaneously addressing both the exterior and interior, using both ascending and descending herbs, and combining strength and gentleness.

The application relates to an application of a traditional Chinese medicine composition in a drug for viral pneumonia, which comprises 10-15 parts of wind-preventing, 10-15 parts of perilla leaf, 2-6 parts of Ephedra, 7-9 parts of Schisandra chinensis, 7-9 parts of white ginkgo, 7-9 parts of bitter almond, 7-9 parts of purple aster, 7-9 parts of dogwood fruit and 7-9 parts of lily of the valley. The traditional Chinese medicine composition can obviously inhibit the increase of the lung index of respiratory syncytial virus (RSV) infected mice and has a better treatment effect on viral pneumonia.

This invention relates to the field of compound essential oils of traditional Chinese medicine, and particularly to a compound essential oil of traditional Chinese medicine for the adjuvant intervention against Streptococcus pneumoniae and its preparation method. The raw materials include the following by weight: 3-8 parts of patchouli essential oil; 2-6 parts of clove essential oil; 2-5 parts of costus root essential oil; 2-6 parts of nard essential oil; 3-7 parts of calamus essential oil; 1-4 parts of asarum essential oil; 3-8 parts of peppermint essential oil; 2-6 parts of artemisia essential oil; 3-7 parts of eupatorium essential oil; 45-80 parts of base oil; 2-5 parts of solubilizer; and 1-3 parts of penetration enhancer. This invention addresses the core issues of "respiratory inflammation, sputum accumulation, and decreased body defense" caused by Streptococcus pneumoniae. Through the scientific formulation of active molecules from nine kinds of Chinese herbal essential oils, a comprehensive synergistic system is formed, which has the functions of "antibacterial and antiviral, anti-inflammatory and lung-clearing, expectorant and cough-relieving, and enhanced defense." It features strong synergistic activity of active molecules, high specificity, high retention and utilization rate of active molecules, safe and convenient use, wide applicability, and simple preparation process.

Abstract: This invention discloses a traditional Chinese medicine composition (Da Zhuque Decoction) with multi-target antiviral and anti-inflammatory activities, its preparation method, and its application. The composition consists of the following raw materials in parts by weight: Alisma plantago-aquatica 2-4 parts, Prunus armeniaca 4-6 parts, Chrysanthemum indicum 4-6 parts, Artemisia annua 5-7 parts, Morus alba leaf 5-7 parts, Gypsum 5-7 parts, Poria cocos 7-9 parts, Scutellaria baicalensis 8-10 parts, Rehmannia glutinosa 8-10 parts, Plantago asiatica 11-13 parts, Taraxacum mongolicum 14-16 parts, and Glycyrrhiza uralensis 3-5 parts. This invention overcomes the limitations of traditional qualitative formulation of traditional Chinese medicines. By limiting the specific synergistic ratio of artemisinin and baicalin (1:2.5~3.0), it achieves highly efficient inhibition of respiratory viruses (IC50=12.5μg / mL) and significant downregulation of inflammatory factors (IL-6, TNF-α). Meanwhile, the preparation process of "plaster decoction first - licorice extraction alone" solves the problem of easy decomposition of heat-sensitive components, increasing the artemisinin retention rate to over 95%. This invention has a clear material basis, controllable quality, and is suitable for preparing drugs or health products for the prevention and treatment of viral pneumonia.

This invention relates to the field of biomedicine, specifically to the application of banana fruit extract in inhibiting influenza virus or treating influenza viral pneumonia. This invention found that banana fruit extract has a certain inhibitory effect on influenza virus in vitro, maintaining its effect for 48 hours after viral infection. In vivo antiviral tests showed that banana fruit extract effectively improved viral pneumonia caused by influenza virus, with a significant difference compared to the virus control group. Therefore, banana fruit extract has a certain inhibitory effect on influenza virus both in vitro and in vivo, and can effectively improve viral pneumonia caused by influenza virus in mice, demonstrating good application potential and warranting further in-depth research and clinical application. This provides technical support for subsequent research and application.